These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28900175)

  • 21. Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window.
    Gillis A; Sreenivasan V; Christie MJ
    Mol Pharmacol; 2020 Oct; 98(4):410-424. PubMed ID: 32665252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms of fentanyl mediated β-arrestin biased signaling.
    de Waal PW; Shi J; You E; Wang X; Melcher K; Jiang Y; Xu HE; Dickson BM
    PLoS Comput Biol; 2020 Apr; 16(4):e1007394. PubMed ID: 32275713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encoding mu-opioid receptor biased agonism with interaction fingerprints.
    Hernández-Alvarado RB; Madariaga-Mazón A; Cosme-Vela F; Marmolejo-Valencia AF; Nefzi A; Martinez-Mayorga K
    J Comput Aided Mol Des; 2021 Nov; 35(11):1081-1093. PubMed ID: 34713377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of novel LP1-based analogues with enhanced delta opioid receptor profile.
    Pasquinucci L; Turnaturi R; Prezzavento O; Arena E; Aricò G; Georgoussi Z; Parenti R; Cantarella G; Parenti C
    Bioorg Med Chem; 2017 Sep; 25(17):4745-4752. PubMed ID: 28734666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand based conformational space studies of the μ-opioid receptor.
    Sena DM; Cong X; Giorgetti A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists.
    Chen SR; Ke YY; Yeh TK; Lin SY; Ou LC; Chen SC; Chang WT; Chang HF; Wu ZH; Hsieh CC; Law PY; Loh HH; Shih C; Lai YK; Yeh SH; Ueng SH
    Eur J Med Chem; 2017 Jan; 126():202-217. PubMed ID: 27776274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic and thermodynamic insights into sodium ion translocation through the μ-opioid receptor from molecular dynamics and machine learning analysis.
    Hu X; Wang Y; Hunkele A; Provasi D; Pasternak GW; Filizola M
    PLoS Comput Biol; 2019 Jan; 15(1):e1006689. PubMed ID: 30677023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular details of dimerization kinetics reveal negligible populations of transient µ-opioid receptor homodimers at physiological concentrations.
    Meral D; Provasi D; Prada-Gracia D; Möller J; Marino K; Lohse MJ; Filizola M
    Sci Rep; 2018 May; 8(1):7705. PubMed ID: 29769636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the Putative Binding Site of a Benzimidazole Opioid (Etazene) and Its Metabolites at µ-Opioid Receptor: A Human Liver Microsomal Assay and Systematic Computational Study.
    Chaturvedi K; Hewamanna I; Pandey P; Khan W; Wang YH; Chittiboyina AG; Doerksen RJ; Godfrey M
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand.
    Parenti C; Turnaturi R; Aricò G; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
    Life Sci; 2012 Jun; 90(25-26):957-61. PubMed ID: 22580287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane.
    Sader S; Anant K; Wu C
    Phys Chem Chem Phys; 2018 Jan; 20(3):1724-1741. PubMed ID: 29265141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability.
    Crowley RS; Riley AP; Sherwood AM; Groer CE; Shivaperumal N; Biscaia M; Paton K; Schneider S; Provasi D; Kivell BM; Filizola M; Prisinzano TE
    J Med Chem; 2016 Dec; 59(24):11027-11038. PubMed ID: 27958743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist-dependent attenuation of mu-opioid receptor-mediated G-protein activation in the dorsal root ganglia of neuropathic rats.
    Obara I; Gunduz Cinar O; Starowicz K; Benyhe S; Borsodi A; Przewlocka B
    J Neural Transm (Vienna); 2010 Apr; 117(4):421-9. PubMed ID: 20213428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular insights into the biased signaling mechanism of the μ-opioid receptor.
    Cong X; Maurel D; Déméné H; Vasiliauskaité-Brooks I; Hagelberger J; Peysson F; Saint-Paul J; Golebiowski J; Granier S; Sounier R
    Mol Cell; 2021 Oct; 81(20):4165-4175.e6. PubMed ID: 34433090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Novel µ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening.
    Poli G; Dimmito MP; Mollica A; Zengin G; Benyhe S; Zador F; Stefanucci A
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31717871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
    Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
    Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of Biased Mu-Opioid Receptor Agonists for the Treatment of Pain.
    Ma M; Li X; Tong K; Cheng J; Yu Z; Ren F; Zhong B; Shi W
    ChemMedChem; 2020 Jan; 15(1):155-161. PubMed ID: 31729174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designing safer analgesics: a focus on μ-opioid receptor pathways.
    Pergolizzi JV; LeQuang JA; Taylor R; Ossipov MH; Colucci D; Raffa RB
    Expert Opin Drug Discov; 2018 Oct; 13(10):965-972. PubMed ID: 30175624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation.
    Convertino M; Samoshkin A; Viet CT; Gauthier J; Li Fraine SP; Sharif-Naeini R; Schmidt BL; Maixner W; Diatchenko L; Dokholyan NV
    PLoS One; 2015; 10(11):e0142826. PubMed ID: 26554831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities.
    Harland AA; Yeomans L; Griggs NW; Anand JP; Pogozheva ID; Jutkiewicz EM; Traynor JR; Mosberg HI
    J Med Chem; 2015 Nov; 58(22):8952-69. PubMed ID: 26524472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.